>>> EPIDEMIOLOGISTS ARE CONTINUING TO TRACK THE SPREAD

CONTINUING TO TRACK THE SPREAD OF CORONAVIRUS.

OF CORONAVIRUS. WE NOW HAVE FIRST CONFIRMED

WE NOW HAVE FIRST CONFIRMED CASES OF THE VIRUS IN PLACES

CASES OF THE VIRUS IN PLACES LIKE BRAZIL, NORWAY, PAKISTAN,

LIKE BRAZIL, NORWAY, PAKISTAN, GREECE, AND GEORGIA.

GREECE, AND GEORGIA. IN MANY CASES, WE CAN IDENTIFY

IN MANY CASES, WE CAN IDENTIFY HOW THE PERSON GOT THE VIRUS,

HOW THE PERSON GOT THE VIRUS, WHAT THEIR EXPOSURE WAS.

WHAT THEIR EXPOSURE WAS. THE OTHER WAY TO THINK ABOUT

THE OTHER WAY TO THINK ABOUT THIS IS SOMETHING CALLED

THIS IS SOMETHING CALLED COMMUNITY SPREAD.

COMMUNITY SPREAD. THAT IS WHEN CASES START

THAT IS WHEN CASES START APPEARING WITHOUT KNOWN CASES OF

APPEARING WITHOUT KNOWN CASES OF EXPOSURE.

EXPOSURE. FOR BRAZIL, IN EXAMPLE.

FOR BRAZIL, IN EXAMPLE. IN NORWAY, THE PERSON HAD JUST

IN NORWAY, THE PERSON HAD JUST RETURNED FROM CHINA.

RETURNED FROM CHINA. BUT IN SOME COUNTRIES, THEY

BUT IN SOME COUNTRIES, THEY ALREADY HAVE COMMUNITY SPREAD.

ALREADY HAVE COMMUNITY SPREAD. THAT INCLUDES HONG KONG, ITALY,

THAT INCLUDES HONG KONG, ITALY, IRAN, SINGAPORE, SOUTH KOREA,

IRAN, SINGAPORE, SOUTH KOREA, TAIWAN, AND THAILAND.

TAIWAN, AND THAILAND. SO THAT MEANS PEOPLE ARE SHOWING

SO THAT MEANS PEOPLE ARE SHOWING UP WITH THE VIRUS AND IT IS NOT

UP WITH THE VIRUS AND IT IS NOT CLEAR HOW THEY GOT IT.

CLEAR HOW THEY GOT IT. WELL, TONIGHT, WE HAVE WHAT

WELL, TONIGHT, WE HAVE WHAT APPEARS TO BE THE FIRST CASE OF

APPEARS TO BE THE FIRST CASE OF COMMUNITY SPREAD HERE IN THE

COMMUNITY SPREAD HERE IN THE UNITED STATES, IN NORTHERN

UNITED STATES, IN NORTHERN CALIFORNIA.

CALIFORNIA. THE ORIGINS OF THIS CASE IS

THE ORIGINS OF THIS CASE IS UNKNOWN.

UNKNOWN. YESTERDAY, THE CDC SAID THAT

YESTERDAY, THE CDC SAID THAT THIS WAS LIKELY TO HAPPEN.

THIS WAS LIKELY TO HAPPEN. THEY ALSO EMPHASIZED THAT PEOPLE

THEY ALSO EMPHASIZED THAT PEOPLE SHOULD NOT PANIC.

SHOULD NOT PANIC. HERE TO EXPLAIN THE TRAJECTORY

HERE TO EXPLAIN THE TRAJECTORY OF THIS VIRUS, DR. PETER JOTEZ,

OF THIS VIRUS, DR. PETER JOTEZ, THE DEAN AT THE BAYLOR COLLEGE

THE DEAN AT THE BAYLOR COLLEGE OF MEDICINE.

OF MEDICINE. BACK IN 2014, EXPLAINED TO US

BACK IN 2014, EXPLAINED TO US HOW EBOLA VIRUS WORKS.

HOW EBOLA VIRUS WORKS. SO, DOCTOR, LET’S START WITH

SO, DOCTOR, LET’S START WITH THIS -- THE -- THE NEWS ABOUT

THIS -- THE -- THE NEWS ABOUT COMMUNITY SPREAD.

COMMUNITY SPREAD. THE CDC, ESSENTIALLY, SAYING

THE CDC, ESSENTIALLY, SAYING THIS WAS INEVITABLE.

THIS WAS INEVITABLE. WHAT DOES IT MEAN IF THERE IS A

WHAT DOES IT MEAN IF THERE IS A CASE IN THE U.S. THAT DOESN’T

CASE IN THE U.S. THAT DOESN’T HAVE ANY KNOWN LINKS TO ANY OF

HAVE ANY KNOWN LINKS TO ANY OF THE SORT OF MAIN COUNTRIES?

THE SORT OF MAIN COUNTRIES? >> WELL, YOU KNOW, FIRST OF ALL,

>> WELL, YOU KNOW, FIRST OF ALL, THANKS FOR HAVING ME BACK.

THANKS FOR HAVING ME BACK. YOU KNOW, WHAT WE HAVE SEEN NOW

YOU KNOW, WHAT WE HAVE SEEN NOW IS THAT THERE’S TRANSMISSION IN

IS THAT THERE’S TRANSMISSION IN MULTIPLE COUNTRIES.

MULTIPLE COUNTRIES. THE COUNTRIES THAT YOU

THE COUNTRIES THAT YOU MENTIONED, INCLUDING ITALY AND

MENTIONED, INCLUDING ITALY AND IRAN.

IRAN. AND NOW, WE MAY HAVE TO ADD THE

AND NOW, WE MAY HAVE TO ADD THE UNITED STATES TO THAT LIST.

UNITED STATES TO THAT LIST. YOU KNOW, THE WORLD HEALTH

YOU KNOW, THE WORLD HEALTH ORGANIZATION IS NOT OFFICIALLY

ORGANIZATION IS NOT OFFICIALLY CALLING THIS A PANDEMIC YET.

CALLING THIS A PANDEMIC YET. BUT WE SEEM TO BE INCHING IN

BUT WE SEEM TO BE INCHING IN THAT DIRECTION.

THAT DIRECTION. AND THE CONCERN IS THAT WE’RE

AND THE CONCERN IS THAT WE’RE GOING TO START SEEING A FOOTHOLD

GOING TO START SEEING A FOOTHOLD THAT THIS VIRUS GAINS IN THE

THAT THIS VIRUS GAINS IN THE UNITED STATES.

UNITED STATES. AND THE EVIDENCE FOR THAT IS

AND THE EVIDENCE FOR THAT IS PERSON-TO-PERSON ONGOING

PERSON-TO-PERSON ONGOING TRANSMISSION.

TRANSMISSION. THE PRESIDENT, TONIGHT, TRIED TO

THE PRESIDENT, TONIGHT, TRIED TO EMPHASIZE THE FEW -- THE SMALL

EMPHASIZE THE FEW -- THE SMALL NUMBERS OF 15.

NUMBERS OF 15. BUT THAT’S -- THAT’S NOT THE

BUT THAT’S -- THAT’S NOT THE POINT.

POINT. THE POINT IS WE KNOW THESE

THE POINT IS WE KNOW THESE NUMBERS ARE GOING TO GO UP.

NUMBERS ARE GOING TO GO UP. WE ARE GOING TO START SEEING

WE ARE GOING TO START SEEING HUMAN-TO-HUMAN TRANSMISSION.

HUMAN-TO-HUMAN TRANSMISSION. AND WE REALLY HAVE TO GET READY

AND WE REALLY HAVE TO GET READY FOR THIS AND PROTECT OUR TWO

FOR THIS AND PROTECT OUR TWO MOST-VULNERABLE POPULATIONS.

MOST-VULNERABLE POPULATIONS. >> WHICH ARE?

>> WHICH ARE? >> WELL, NUMBER ONE, ARE THE

>> WELL, NUMBER ONE, ARE THE HEALTHCARE WORKERS.

HEALTHCARE WORKERS. WE SUEAW IN WUHAN, IN CENTRAL

WE SUEAW IN WUHAN, IN CENTRAL CHINA, THERE WERE MORE THAN A

CHINA, THERE WERE MORE THAN A THOUSAND HEALTHCARE WORKERS

THOUSAND HEALTHCARE WORKERS AFFECTED.

AFFECTED. THERE WERE SIX DEATHS.

THERE WERE SIX DEATHS. YOU CAN IMAGINE WHAT WOULD

YOU CAN IMAGINE WHAT WOULD HAPPEN IN THE UNITED STATES IF

HAPPEN IN THE UNITED STATES IF WE SAW AN EPIDEMIC AMONG OUR

WE SAW AN EPIDEMIC AMONG OUR HEALTHCARE PROVIDERS.

HEALTHCARE PROVIDERS. THAT WOULD CAUSE A LOT OF

THAT WOULD CAUSE A LOT OF CONCERN AND PANIC.

CONCERN AND PANIC. SO WE ABSOLUTELY NEED TO PROTECT

SO WE ABSOLUTELY NEED TO PROTECT THEM BY PROVIDING THE PPE, THE

THEM BY PROVIDING THE PPE, THE PERSONAL PROTECT IVIVE EQUIPMENT

PERSONAL PROTECT IVIVE EQUIPMENT THAT THEY NEED.

THAT THEY NEED. WE ALSO NEED A BETTER

WE ALSO NEED A BETTER DIAGNOSTIC.

DIAGNOSTIC. BECAUSE WE ARE LEARNING ABOUT

BECAUSE WE ARE LEARNING ABOUT THIS VIRUS THAT MANY PEOPLE

THIS VIRUS THAT MANY PEOPLE DON’T PRESENT WITH CLASSIC

DON’T PRESENT WITH CLASSIC RESPIRATORY SYMPTOMS.

RESPIRATORY SYMPTOMS. WE SAW IN CHINA, SOMETIMES THEY

WE SAW IN CHINA, SOMETIMES THEY PRESENT WITH ABDOMINAL SIMYMPTOM

PRESENT WITH ABDOMINAL SIMYMPTOM THEY WERE MISTAKENLY PUT IN THE

THEY WERE MISTAKENLY PUT IN THE SURGICAL WARD.

SURGICAL WARD. WE HAVE SEEN EPIDEMICS IN

WE HAVE SEEN EPIDEMICS IN HOSPITALS.

HOSPITALS. SO GETTING THAT DIAGNOSTIC TEST,

SO GETTING THAT DIAGNOSTIC TEST, OTHER THAN THE PPE, IS A BIG

OTHER THAN THE PPE, IS A BIG PRIORITY.

PRIORITY. THE SECOND, OF COURSE, IS OUR

THE SECOND, OF COURSE, IS OUR OLDER POPULATION BECAUSE WE HAVE

OLDER POPULATION BECAUSE WE HAVE SEEN THE HIGHER MORTALITY RATES

SEEN THE HIGHER MORTALITY RATES AMONG THOSE OVER THE AGE OF 60

AMONG THOSE OVER THE AGE OF 60 AND THOSE WITH UNDERLYING

AND THOSE WITH UNDERLYING CHRONIC CONDITIONS, SUCH AS

CHRONIC CONDITIONS, SUCH AS DIABETES OR HYPERTENSION.

DIABETES OR HYPERTENSION. SO WE WILL SEE AN INCREASE IN

SO WE WILL SEE AN INCREASE IN NUMBERS.

NUMBERS. THE BIG QUESTION IS ARE WE GOING

THE BIG QUESTION IS ARE WE GOING TO BE LOOKING AT SMALL,

TO BE LOOKING AT SMALL, COMMUNITY-LEVEL TRANSMISSIONS IN

COMMUNITY-LEVEL TRANSMISSIONS IN A FEW CITIES ACROSS THE COUNTRY?

A FEW CITIES ACROSS THE COUNTRY? OR ARE WE GOING TO BE LOOKING AT

OR ARE WE GOING TO BE LOOKING AT SOMETHING MUCH LARGER?

SOMETHING MUCH LARGER? THIS IS A NEW VIRUS AGENT WE

THIS IS A NEW VIRUS AGENT WE HAVE ABSOLUTELY NO WAY OF

HAVE ABSOLUTELY NO WAY OF PREDICTING.

PREDICTING. SO THE PRUDENT THING IS, AS THE

SO THE PRUDENT THING IS, AS THE CDC TALKED ABOUT YESTERDAY, IS

CDC TALKED ABOUT YESTERDAY, IS TO ANTICIPATE THE WORST AND THE

TO ANTICIPATE THE WORST AND THE HOPE FOR THE BEST.

HOPE FOR THE BEST. >> WHEN YOU SAY IT’S A NEW VIRUS

>> WHEN YOU SAY IT’S A NEW VIRUS AGENT, WHAT DO WE KNOW ABOUT

AGENT, WHAT DO WE KNOW ABOUT THIS -- THIS VIRUS?

THIS -- THIS VIRUS? AND WHAT ARE THE VARIABLES THAT

AND WHAT ARE THE VARIABLES THAT WILL DETERMINE JUST -- JUST HOW

WILL DETERMINE JUST -- JUST HOW FAR IT SPREADS?

FAR IT SPREADS? >> WELL, YOU KNOW, WE’VE SEEN

>> WELL, YOU KNOW, WE’VE SEEN SOME EARLY NUMBERS COMING OUT OF

SOME EARLY NUMBERS COMING OUT OF CHINA SUGGESTING THAT IT’S A

CHINA SUGGESTING THAT IT’S A PRETTY HIGHLY-TRANSMISSIBLE

PRETTY HIGHLY-TRANSMISSIBLE VIRUS.

VIRUS. SO LET ME GIVE YOU AN EXAMPLE.

SO LET ME GIVE YOU AN EXAMPLE. SEASONAL FLU HAS A NUMBER

SEASONAL FLU HAS A NUMBER ASSIGNED TO IT, A NUMBER CALLED

ASSIGNED TO IT, A NUMBER CALLED THE REPRODUCTIVE NUMBER, 1.3.

THE REPRODUCTIVE NUMBER, 1.3. THAT MEANS IF A SINGLE PERSON

THAT MEANS IF A SINGLE PERSON GETS FLU, ON AVERAGE, 1.3 OTHER

GETS FLU, ON AVERAGE, 1.3 OTHER INDIVIDUALS WILL GET IT.

INDIVIDUALS WILL GET IT. IT’S TRANSMISSIBLE BUT NOT

IT’S TRANSMISSIBLE BUT NOT NEARLY AMONG THE

NEARLY AMONG THE MOST-TRANSMISSIBLE AGENTS WE

MOST-TRANSMISSIBLE AGENTS WE KNOW ABOUT.

KNOW ABOUT. FOR THIS ONE, THE NUMBERS GO AS

FOR THIS ONE, THE NUMBERS GO AS HIGH AS 3.58 UP TO 4.

HIGH AS 3.58 UP TO 4. SO THAT MEANS IT IS A VERY

SO THAT MEANS IT IS A VERY HIGHLY TRANSMISSIBLE VIRUS.

HIGHLY TRANSMISSIBLE VIRUS. WE ARE ALSO HEARING DIFFERENT

WE ARE ALSO HEARING DIFFERENT CASE ABOUT THE FATALITY RATE.

CASE ABOUT THE FATALITY RATE. INITIALLY, COMING OUT OF CHINA

INITIALLY, COMING OUT OF CHINA SAYING 2%.

SAYING 2%. OTHERS SAYING THAT DOESN’T

OTHERS SAYING THAT DOESN’T REALLY ACCOUNT FOR THE NUMBER OF

REALLY ACCOUNT FOR THE NUMBER OF PEOPLE WITH LOW-GRADE SYMPTOMS

PEOPLE WITH LOW-GRADE SYMPTOMS OR WHO HAVE NO SYMPTOMS AT ALL.

OR WHO HAVE NO SYMPTOMS AT ALL. BUT YESTERDAY, BRUCE ELWORD GAVE

BUT YESTERDAY, BRUCE ELWORD GAVE US SOME VERY CONCERNING NEWS

US SOME VERY CONCERNING NEWS THAT YES, INDEED, THAT 2% CASE

THAT YES, INDEED, THAT 2% CASE FATALITY RATE LOOKS REAL.

FATALITY RATE LOOKS REAL. AND IF THAT’S THE CASE, THAT IS

AND IF THAT’S THE CASE, THAT IS OF GREAT CONCERN BECAUSE THE FLU

OF GREAT CONCERN BECAUSE THE FLU IS A BAD VIRUS.

IS A BAD VIRUS. AND AS THE PRESIDENT LEARNED

AND AS THE PRESIDENT LEARNED ABOUT FLU TODAY, THAT IT CAN

ABOUT FLU TODAY, THAT IT CAN KILL UP TO 40,000 AMERICANS,

KILL UP TO 40,000 AMERICANS, 60,000 AMERICANS.

60,000 AMERICANS. A CASE FATALITY RATE OF 2% IS 10

A CASE FATALITY RATE OF 2% IS 10 TO 20 TIMES HIGHER THAN FLU.

TO 20 TIMES HIGHER THAN FLU. SO I THINK IT’S -- IT’S -- IT’S

SO I THINK IT’S -- IT’S -- IT’S AN ART, RIGHT, TO CONVEY BAD

AN ART, RIGHT, TO CONVEY BAD NEWS WITH

NEWS WITH NEWS WITHOUT -- WITHOUT

NEWS WITHOUT -- WITHOUT SPREADING PANIC.

SPREADING PANIC. THIS IS A SERIOUS VIRUS

THIS IS A SERIOUS VIRUS INFECTION AND IT’S GOING TO TAKE

INFECTION AND IT’S GOING TO TAKE ALL HANDS ON DECK TO DO THIS.

ALL HANDS ON DECK TO DO THIS. I KNOW THE PRESIDENT DID THE

I KNOW THE PRESIDENT DID THE RIGHT THING IN THE SENSE OF

RIGHT THING IN THE SENSE OF TRYING TO FIND SOMEONE TO

TRYING TO FIND SOMEONE TO OVERSEE OPERATIONS, RECOGNIZING

OVERSEE OPERATIONS, RECOGNIZING THAT THIS GOES BEYOND THE HEALTH

THAT THIS GOES BEYOND THE HEALTH SECTOR.

SECTOR. LOOK, WHEN WE HAD TO COMBAT

LOOK, WHEN WE HAD TO COMBAT EBOLA, WE ACTUALLY HAD TO SEND

EBOLA, WE ACTUALLY HAD TO SEND IN THE 101st AIRBORNE DIVISION.

IN THE 101st AIRBORNE DIVISION. WE NEEDED THE U.S. MILITARY TO

WE NEEDED THE U.S. MILITARY TO HELP US.

HELP US. SO HE IS RIGHT TO ANTICIPATE

SO HE IS RIGHT TO ANTICIPATE THAT WE’RE GOING TO HAVE TO GO

THAT WE’RE GOING TO HAVE TO GO ACROSS MULTIPLE AGENCIES,

ACROSS MULTIPLE AGENCIES, POSSIBLY INCLUDING THE U.S.

POSSIBLY INCLUDING THE U.S. MILITARY.

MILITARY. WHETHER VICE PRESIDENT PENCE IS

WHETHER VICE PRESIDENT PENCE IS ACTUALLY GOING TO DEVOTE HIS

ACTUALLY GOING TO DEVOTE HIS FULL TIME TO THIS, YOU KNOW,

FULL TIME TO THIS, YOU KNOW, WHEN RON CLANE WAS DOING THIS,

WHEN RON CLANE WAS DOING THIS, IT WAS 24/7 FOR HIM AND HIS

IT WAS 24/7 FOR HIM AND HIS STAFF.

STAFF. SO I DON’T KNOW HOW COMMITTED

SO I DON’T KNOW HOW COMMITTED THE VICE PRESIDENT’S GOING TO BE